Michael Best and Friedrich LLP: Welcomes Andrew T. Dufresne, Ph.D.

Contact:

Jennifer R. Rupkey

Director, Marketing & Business Development
Director

Direct Dial: 414.225.8262

E-Mail: jrrupkey@michaelbest.com

MICHAEL BEST WELCOMES ANDREW T. DUFRESNE, PH.D.

Madison, WI (October 10, 2013) – Michael Best & Friedrich LLP is pleased to announce that Andrew T. Dufresne, Ph.D., has joined the firm’s Intellectual Property Practice Group, effective October 1, 2013.

Dr. Dufresne focuses his practice on issues relating to biotechnology and pharmaceuticals. He was an attorney in the Madison office in 2010, providing thorough and attentive intellectual property counseling to clients ranging from industry to academia. He has particular expertise in the chemical, pharmaceutical and biotechnology sectors, and has assisted clients developing technologies such as small-molecule and peptide-based pharmaceuticals, antimicrobials, drug screening assays, adjuvants and vaccine formulations, gene therapy techniques, diagnostic assays, transgenic animals, biofuel production methods, cloning and expression vectors, pharmaceutical and food coatings, and chemical purification systems. He also has experience preparing and prosecuting U.S. and foreign patent applications, conducting patentability studies, drafting invalidity, infringement and freedom-to-operate opinions, and initiating patent reexaminations before the U.S. Patent and Trademark Office.

Prior to joining Michael Best, Dr. Dufresne worked as a post-doctoral scholar at the G.W. Hooper Foundation at University of California – San Francisco, in the laboratory of Dr. Don Ganem, researching viral interactions with the miRNA biogenesis pathway and mechanisms of eukaryotic mRNA turnover. Outside of the firm, Dr. Dufresne is active with the American Intellectual Property Law Association, the American Society for Microbiology, and the Sigma Xi Scientific Research Society.

Dufresne received his B.A. in biology and chemistry, summa cum laude, in 2001 from Gustavus Adolphus College, earned his Ph.D. in molecular genetics and microbiology in 2005 from Duke University, and received his J.D. from University of California Berkeley School of Law in 2010.